Compare ZURA & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZURA | OPFI |
|---|---|---|
| Founded | 2022 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 252.9M | 288.7M |
| IPO Year | N/A | N/A |
| Metric | ZURA | OPFI |
|---|---|---|
| Price | $5.17 | $10.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | $11.38 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 666.0K | 513.3K |
| Earning Date | 11-13-2025 | 03-04-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.14 |
| Revenue | N/A | ★ $335,423,000.00 |
| Revenue This Year | N/A | $120.32 |
| Revenue Next Year | N/A | $10.85 |
| P/E Ratio | ★ N/A | $73.55 |
| Revenue Growth | N/A | ★ 28.69 |
| 52 Week Low | $0.97 | $7.54 |
| 52 Week High | $5.75 | $17.73 |
| Indicator | ZURA | OPFI |
|---|---|---|
| Relative Strength Index (RSI) | 62.01 | 42.08 |
| Support Level | $4.75 | $9.90 |
| Resistance Level | $5.28 | $10.49 |
| Average True Range (ATR) | 0.51 | 0.33 |
| MACD | -0.01 | -0.11 |
| Stochastic Oscillator | 61.36 | 15.29 |
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.